mTOR inhibitors (University of Basel/PIQUR Therapeutics)

N/A

Report date: 2025/03/20 16:03:18
NME

Base Information

Drug NamemTOR inhibitors (University of Basel/PIQUR Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsEpilepsyNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Basel
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A